Ataturk University
Erzurum, 25100, Turkey (Türkiye)
NCT Number: NCT03538483
Serratus plane block (SPB) was first described in 2013 by Blanco and designed to primarily block the thoracic intercostal nerves. And this block provides sufficient analgesia lateral anterior and posterior part of thoracic wall.Erector Spinae Plane Block (ESPB) is a newly described and effective interfascial plane block for thoracic and abdominal surgery. It was first described by Forero et al. in 2016, effectiveness being reported in four cases. The aim of this study is to compare Serratus plane block and erector spinae plane block on postoperative pain in patients undergoing modified radical mastectomy and axillary lymph node dissection
Looking for future studies?
Notify Me18 year–65 year
Female
Interventional
Not applicable
Erzurum, 25100, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
30 ml %0,25 bupivacaine
20 ml %0,25 bupivacaine
Time frame: First 24 hours
First 24 hours total fentanyl consumption with patient controlled analgesia
Time frame: postoperative first24 hours
Post operative pain will be evaluated with a Visual Analogue Scale (VAS) score of 0-10 (0= no pain and 10= worst imaginable pain) at first hour postoperatively
Time frame: First hour
The block time was defined as the period between the insertion of the needle and termination of local anesthetic administration
Ataturk University
Other
Erector Spinae Plane Block Versus Serratus Plane Block on Postoperative Opioid Consumption for Modified Radical Mastectomy and Axillary Lymph Node Dissection
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07724678
Agnosia, Breast Cancer
Altındağ, Ankara, Turkey (Türkiye)
View Trial DetailsNCT07035275
Analgesic Use, Breast Cancer
Ankara, Yenimahalle, Turkey (Türkiye)
View Trial DetailsNCT00210210
Agnosia, Breast Cancer
Bordeaux, France
View Trial DetailsNCT03653988
Anesthesia, Breast Cancer
Iowa City, Iowa, United States
View Trial Details